The novel therapy of the medication represents a major development in the management of the condition. Unlike existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP) – providing enhanced sugar regulation and anticipated weight loss. Researchers are studying its long-term benef… Read More